SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

BRIEF-Sigilon Therapeutics Posts Quarterly Loss Per Share Of $0.60

05/10/2021 17:29
BRIEF-Sigilon Therapeutics Posts Quarterly Loss Per Share Of $0.60

- Sigilon Therapeutics Inc SGTX.O:

  • SIGILON THERAPEUTICS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

  • SIGILON THERAPEUTICS, INC. - CASH WAS $178.8 MILLION AS OF MARCH 31, 2021

  • SIGILON THERAPEUTICS, INC. QTRLY LOSS PER SHARE $0.60

  • SIGILON THERAPEUTICS - ON TRACK TO FILE CTA AND/OR IND FOR MPS-1 IN Q2 OF 2021, ANTICIPATES ADDITIONAL REGULATORY FILINGS BEFORE END OF 2022

  • SIGILON THERAPEUTICS, INC. - EXPECTS TO DISCLOSE UP TO 9 MONTHS OF FOLLOW UP DATA ON STUDY OF SIG-001 FOR 3-4 PATIENTS IN Q3 OF 2021

  • SIGILON THERAPEUTICS, INC. - FOR STUDY OF SIG-001, EXPECTS TO COMPLETE ENROLLMENT OF STUDY IN SECOND HALF OF 2021

Source text for Eikon: ID:nGNX5dTDH9

Further company coverage: SGTX.O


(([email protected];))